.e., when it is unlikely that influenza would have influenced the returns, was 21 % higher among non-vaccinated employees than in vaccinated employees, the difference being due to certified illness of more than three days' duration.
of the vaccine in protecting the individual recipient, and the proportion of the population who are immune before vaccination. The benefits to be secured from vaccination will also depend on how many employees accept the offer of vaccine, and on the characteristics of those who accept or do not accept the offer. If, for example, a high proportion of vaccinated employees frequently move to new jobs, the value of the vaccination programme to the factory concerned would be impaired. This paper describes the factors associated with acceptance of influenza vaccination by employees in the factories, offices, and warehouses of a large pharmaceutical firm, the Boots Company Ltd, in the north-midlands of England.
Materials and methods The factory
The factories and offices studied together occupy one of the manufacturing sites of the company, which does not manufacture influenza vaccine nor is vaccine distributed from the site. The working conditions in all sections of the factory, production, packing, despatch, and offices, are of a high standard.
Vaccination
All employees were offered a single dose of influenza vaccine in 1971 and also in 1972. The offers were made in late November by individual letters from the company medical officer, supported by articles in the company journal and by means of posters.
Vaccination was organized in sessions over a three-day period in early December each year, and was carried out by needle and syringe or jet-gun injector.
The vaccine
Standard commercial bivalent influenza vaccine (BDH Admune) was used in a dose of 1 0 ml. In 1971 approximately half the doses were given with a needle and syringe and half with a portable injection gun (Port-o-jet, Schuco Scientific Limited) . In 1972 almost all the doses were given by injector gun.
Returns of vaccine acceptance and sickness absence Arrangements were made to obtain computer returns to provide the following information:
1. A census of both 'works' and 'staff' employees in the factory according to age group, sex, marital status of women, and vaccination status.
Works employees consisted of those paid weekly; most worked in production or despatch departments. Staff employees largely consisted of office and management workers but included a small number employed in warehousing and distribution. Most staff employees were paid monthly.
2. A print-out for both works and staff employees of the total number of days lost from work due to sickness absence according to age group, sex, marital status in the case of women, and vaccination status. Absence returns included figures of both long-term medically certified illness and short-term (3 days and less) non-certified illness.
Returns were made weekly for works employees and monthly for staff employees. (Taylor, 1968) . This conclusion is supported by the sickness absence records of the vaccinated and unvaccinated employees in the 12 months before they were offered vaccine. A random sample of 26 % of the employees was selected from the computer file and the sample comprised 881 employees who were not vaccinated and 679 who were later to accept vaccination in December 1971. The ratio of days lost from sickness absence in the period was found to be vaccinated/ unvaccinated = 0 74. When the uncertificated short-term absences of three days and less for the April-September period (Table 4 ) that the excess absence among the non-vaccinated employees was confined to illnesses of over three days' duration. Sickness absence was particularly high in those over 60 years of age (6-8 % working days lost compared with 2-9% days lost for the remaining age groups) and acceptance of vaccine was also lowest in this age group (Figure) .
Results

Acceptance
Discussion
The value of influenza vaccination in such places as factories and offices must be affected by the proportion of employees who accept inoculation. An acceptance rate of 42 % was found in the first year of the present study, and a similar rate was also found in the first year of influenza vaccination programmes in a number of other factories and offices in different parts of the United Kingdom (Smith and Pollard, 1973b) . In the second year of the vaccination programme the rate of acceptance fell from 42 to 27% despite the fact that the offer of vaccination was equally well publicized; of those vaccinated in 1971, only 57% accepted the inoculation in 1972. We have observed falls in other factories (unpublished observations) and previousworkers have also recorded a decline of acceptance in successive years (Richardson and Kilpatrick, 1964; Kennedyand Veys, 1966) . It is not clear why acceptance of vaccine declines. One factor may be adverse reactions to the vaccine which although minor are known to be not uncommon (Meichen, Rogan, and Howell, 1962; Howell and Mackenzie, 1964) and may be recorded by as many as two-thirds of the recipients of zonally purified influenza vaccine (unpublished observations). In addition, the outbreak of influenza experienced in January-February 1972 was small, and benefit from vaccination would have been difficult for employees to notice. Thus returns from the Royal College of General Practitioners (personal communication) suggest that in the 1971-72 epidemic only about 3 % of the working-age population had an attack of 'influenza'. Nevertheless, whatever the explanation the fall in take-up rate was appreciable and it is probable that it may be a general phenomenon.
In considering the likely benefit to be secured from influenza vaccination in an industrial population, it is also necessary to take into account the characteristics of the volunteer population. Acceptance of influenza vaccination varied with age and sex ( Figure) , being low in young men and high inmiddleaged women. These observations differ from those of Richardson and Kilpatrick (1964) , who reported that acceptance rates were higher in younger age groups. The different experience may partly be due to the smaller population that was studied, 700 persons compared with 6 000 in the present study. Revaccination was commoner among staff than works employees, and among older than younger agegroups. It is possible, therefore, that vaccination programmes at the present time would be of greater benefit in offices than in factories, particularly in established offices with a high proportion of middleaged women and older employees. The findings also indicate that loss of vaccinated employees should not significantly affect the value of vaccination.
In a six-month period when influenza was unlikely to have influenced the returns, the amount of working time lost from all certificated illness in nonrecipients of influenza vaccine was found to be 21 % higher than in recipients (Table 4) , and the difference remains the same when the two groups of employees are standardized for age and sex. Meichen et al. (1962) , on the other hand, reported that records of certified respiratory illness during nine months prior to vaccination were similar in those who had been vaccinated and in a control group randomly selected from the non-volunteers, matched for age, sex, and length of service. However, the findings reported in the present study indicate that the non-vaccinees represent a different population from the vaccinees, differing in age and sex structure and probably in length of service (Table 3) . Moreover, the figures reported by Meichen et al. (1962) in their Table 4 indicate that the non-vaccinated employees lost from respiratory illness 8-5 % more days per 100 persons at risk than the vaccinated employees over a 10-month period. The excess absence in non-vaccinees we have reported may therefore represent an excess from respiratory illness together with an excess from other certificated illness. There is no reason to believe that the difference in absence figures would not also operate during influenza periods so that, irrespective of the specific effect of the vaccine, absence among those who have accepted influenza vaccine is liable to be lower than among the non-volunteers who did not accept vaccine. It is important that industrial firms should not attribute such differences solely to the beneficial effects of vaccination.
